Cortical-area specific block of genetically determined absence seizures by ethosuximide

Neuroscience

Volumn 123, Issue 1, 2004, Pages 5-9

  Manning, J P A ^a   Richards, D A ^a   Leresche, N ^b   Crunelli, V ^c   Bowery, N G ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b SORBONNE UNIVERSITÉ   (France)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Absence epilepsy; GABAB antagonist; GAERS; Primary somatosensory cortex; Reticular thalamic nucleus; Ventrobasal thalamus

Indexed keywords

3 AMINOPROPYLBUTYLPHOSPHINIC ACID; ETHOSUXIMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG MEGADOSE; ELECTROENCEPHALOGRAM; GENETIC ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; SOMATOSENSORY CORTEX;

EID: 0345549501     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2003.09.026     Document Type: Article

References (30)

1. Avoli M., Gloor P. Interaction of the cortex and thalamus in spike wave discharges of feline generalised penicillin epilepsy. Exp Neurol. 76:1982;196-217.
2. Coenen A.M., Drinkenburg W.H., Inoue M., van Luijtelaar E.L. Genetic models of absence epilepsy, with emphasis on the WAG/Rij strain of rats. Epilepsy Res. 12:1992;75-86.
3. Coulter D.A., Huguenard J.R., Prince D.A. Characterisation of ethosuximide reduction of low-threshold calcium currents in thalamic neurons. Ann Neurol. 25:1989;582-593.
4. 2+ channels is not the entire story. Epilepsy Curr. 2:2002;53-56.
5. Crunelli V., Leresche N. Childhood absence epilepsy genes, channels, neurons and networks . Nat Rev Neurosci. 3:2002;371-382.
6. D'Arcangelo G., D'Antuono M., Biagini G., Warren R., Tancredi V., Avoli M. Thalamocortical oscillations in a genetic model of absence seizures. Eur J Neurosci. 16:2002;2383-2393.
7. Danober L., Deransart C., Depaulis A., Vergnes M., Marescaux C. Pathophysiological mechanisms of genetic absence epilepsy in the rat. Prog Neurobiol. 55:1998;27-57.
8. Ferri R., Iliceto G., Carlucci V. Topographic EEG mapping of 3/s spike-and-wave complexes during absence seizures. Ital J Neurol Sci. 16:1995;541-571.
9. Gloor P., Fariello R.G. Generalized epilepsy some of its cellular mechanisms differ from those of focal epilepsy . Trends Neurosci. 11:1988;63-68.
10. Hosford D.A. Models of primary generalized epilepsy. Curr Opin Neurol. 8:1995;121-125.
11. 2+ channels is an important action of succinimide antiabsence drugs. Epilepsy Curr. 2:2002;49-52.
12. Huguenard J.R., Prince D.A. Intrathalamic rhythmicity studied in vitro nominal T-current modulation causes robust antioscillatory effects . J Neurosci. 14:1994;5485-5502.
13. Leresche N., Parri H.R., Erdemli G., Guyon A., Turner J.P., Williams S.R., Asprodini E., Crunelli V. On the action of the anti-absence drug ethosuximide in the rat and cat thalamus. J Neurosci. 18:1998;4842-4853.
14. B neurotransmission in the control of absence seizures in the rat. Neuroscience. 48:1992;87-93.
15. Marescaux C., Micheletti G., Vergnes M., Depaulis A., Rumbach L., Warter J.M. A model of chronic spontaneous petit mal-like seizures in the rat comparison with pentylenetetrazol-induced seizures . Epilepsia. 25:1984;326-331.
16. Marescaux C., Vergnes M., Depaulis A. Genetic absence epilepsy in rats from Strasbourg a review . J Neural Transm Suppl. 35:1992;37-69.
17. Meeren H.K., Pijn J.P., van Luijtelaar E.L., Coenen A.M., Lopes da Silva F.H. Cortical focus drives widespread corticothalamic networks during spontaneous absence seizures in rats. J Neurosci. 22:2002;1480-1495.
18. Neckelmann D., Amzica F., Steriade M. Spike-wave complexes and fast components of cortically generated seizures III. Synchronizing mechanisms . J Neurophysiol. 80:1998;1480-1494.
19. Neidermeyer E. Primary (idiopathic) generalised epilepsy and underlying mechanisms. Clin Electroencephalogr. 27:1996;1-21.
20. Panayiotopoulos C. Absence epilepsies. Engel J., Pedley T.A. Epilepsy: a comprehensive textbook. 1997;2327-2346 Lippincott-Raven Publishers, Philadelphia.
21. th edition :1998;Academic Press, San Diego.
22. Richards D.A., Manning J.-P.A., Barnes D., Rombola L., Bowery N.G., Caccia S., Leresche N., Crunelli V. Targeting thalamic nuclei is not sufficient for the full anti-absence action of ethosuximide in a rat model of absence epilepsy. Epilepsy Res. 54:2003;97-107.
23. Sayer R.J., Brown A.M., Schwindt P.C., Crill W.E. Calcium currents in acutely isolated human neocortical neurons. J Neurophysiol. 69:1993;1596-1606.
24. Seidenbecher T., Staak R., Pape H.C. Relations between cortical and thalamic cellular activities during absence seizures in rats. Eur J Neurosci. 10:1998;1103-1112.
25. Sherwin A.L. Ethosuximide clinical use . Levy R.H., Mattson R., Meldrum B., Penry J.K., Drisfuss F.E. Antiepileptic drugs. 1989;685-698 Raven Press, New York.
26. Snead O.C. Pharmacological models of generalized absence seizures in rodents. J Neural Transm Suppl. 35:1992;7-19.
27. Steriade M. The GABAergic reticular nucleus a preferential target of corticothalamic projections . Proc Natl Acad Sci USA. 98:2001;3625-3627.
28. Steriade M., Amzica F. Dynamic coupling among neocortical neurons during evoked and spontaneous spike-wave activity. J Neurophysiol. 72:1994;2051-2069.
29. Steriade M., Contreras D. Spike-wave complexes and fast components of cortically generated seizures I. Role of neocortex and thalamus . J Neurophysiol. 80:1998;1439-1455.
30. Vergnes M., Marescaux C., Micheletti G., Depaulis A., Rumbach L., Warter J.-M. Enhancement of spike and wave discharges by GABAmimetic drugs in rats with spontaneous petit-mal-like epilepsy. Neurosci Lett. 44:1984;91-94.